|

Denosumab Clinical Trials

4 actively recruiting trials across 2 locations

Other2 trials

An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting
Phase 2
Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis

Birmingham, Alabama1 trial

Denosumab for Type 1 Diabetes

University of Alabama at Birmingham

Phase 1/2

Westwood, Kansas1 trial

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

The University of Kansas Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.